ANARITA WIDMAIER: Open Payments
NPI 1780467647 · MIAMI SHORES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,701 in 98 payments from 15 companies in 2025. Trend: 2023 $973 · 2024 $2,719 · 2025 $3,701
Food & beverage: $3,621Education: $81
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $561 |
| Regeneron Healthcare Solutions, Inc. | 10 | $521 |
| ABBVIE INC. | 9 | $479 |
| GENZYME CORPORATION | 12 | $435 |
| Incyte Corporation | 10 | $348 |
| Amgen Inc. | 2 | $262 |
| UCB, Inc. | 8 | $214 |
| Galderma Laboratories, L.P. | 5 | $211 |
| Lilly USA, LLC | 2 | $150 |
| Novartis Pharmaceuticals Corporation | 2 | $140 |
Products named: DUPIXENT, TREMFYA, OPZELURA, SKYRIZI, Otezla, Bimzelx, NEMLUVIO, BOTOX.
Industry payments across FL — which companies pay providers there.
